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ABSTRACT
Stroke is the 2nd leading cause of death and 3rd leading cause of disability after cancer and ischemic heart disease.
The recognition of acute stroke symptoms and knowledge about timely and prompt referral of a patient for possible
thrombolysis is a need of time for which general practitioners (as they have to be the first responders many a times
across Pakistan) need to be equipped with the advance knowledge about stroke treatment.
Methods:
In this cross-sectional observational study we assessed a total of 100 GPs practicing within a radius of 60km from a
tertiary care teaching hospital in Islamabad where thrombolysis is being offered routinely to patients with acute ischemic stroke (AIS). They were interviewed using a standard questionnaire designed containing basic questions on stroke
management.
Results:
Of the 100 GPs interviewed, 70% felt that tissue plasminogen activator (tPA) can be used in treating AIS but only 20%
chose tPA as the best treatment option while 31% opted for other agents like citicholine along with antiplatelets plus
tPA.Only 28% were aware that tPA should be given within 3 hours while 64% mentioned intra-arterial thrombolysis as
a treatment option.Only 54% felt the need for good diabetic control and 25% wanted aggressive lowering of blood
pressure. 43% chose normal saline as fluid of choice.
Conclusions:
Majority of the GPs are not aware about the beneficial effects of thrombolysis and are not updated regarding blood
pressure and glucose control in the setting of acute ischemic stroke.
KEYWORDS:
Acute ischemic stroke, thrombolysis, general practitioners
Introduction:

unable to function or to perform work activities. Stroke
has long been recognized as a major cause of work
absenteeism and impaired productivity. The national
annual indirect burden of illness due to stroke in the
United States is estimated to be $75.2 billion [2].
Despite causing significant disability many challenges
remain as clinicians and investigators continue to
design interventions to improve stroke mortality and
disability for all.

Stroke is the 2nd leading cause of death and 3rd
leading cause of disability after cancer and ischemic
heart disease [1]. Stroke is defined as the sudden
non-convulsive, focal neurologic deficit of vascular
origin. It encompasses mainly two types: ischemic
stroke and hemorrhagic stroke. The intensity and
duration of symptoms render many stroke sufferers
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The recognition of acute stroke symptoms and knowledge about timely and prompt referral of a patient for
possible thrombolysis is a need of time for which
general practitioners (as they have to be the first
responders many a times across Pakistan) need to be
equipped with the advance knowledge about acute
ischemic stroke treatment. Intravenous tissue plasminogen activator (tPA) is the treatment of choice in the
setting of acute stroke [3]. The limitations to intravenous thrombolysis in stroke patients in our settings
include: (1) delayed arrival to hospitals due to lack of
awareness about the signs and symptoms of stroke and
also available therapeutic options among the population [4]; (2) lack of enough hospitals offering thrombolysis; (3) economic affordability; and (4) lack of awareness of thrombolytic therapy in stroke both among the
patients and referring physicians, pre-hospital delays
and lack of awareness about stroke thrombolysis
among the medical professionals [5]. We studied the
awareness about the treatment of stroke among
general practitioners (GPs).

Q2: Effective therapies for a patient with acute stroke:
only 20% felt tPA is an effective treatment option.
8% thought antiplatelet agent alone is effective.
2% believed that a neuroprotective agent like
citicholine is effective and 31% considered tPA,
antiplatelet and a neuroprotective agent together
to be beneficial. 39% opted for a combination of
tPA and antiplatelet to be a better treatment
option.

Materials and Methods:
This cross-sectional observational study was conducted
within a radius of 60 km from a tertiary care teaching
hospital in Islamabad (Pakistan) where thrombolysis
(both intravenous and intra-arterial) is being offered
routinely to patients with stroke. A total of 100 GPs
were contacted through various electronic media like
emails, text messages, phone calls, social applications
while some were met at their clinics. They were
interviewed after taking an informed consent using a
standard questionnaire designed containing basic
questions on the management of stroke. They were
asked to fill the questionnaire. The data of the filled
questionnaire by the GPs was compiled and analyzed
using Microsoft Office Excel 2013.

Q3: Window period for tPA: Only 28% GPs were aware
that tPA needs to be given within 3 hours of onset
of stroke; 15% did not know when to give this
drug; 10% felt it can be given up to 12 hours; 22%
felt it can be given within the first 6 hours and 25%
felt it should be given within 4.5 hours.

Results:
A total of 100 GPs completed the questionnaire and
their responses were included as follows:
Q1: Opinion about tPA in the management of acute
stroke: Of the 100 GPs, 70% agreed that tPA can
be used in the treatment of acute stroke; 21%
were not aware of this drug; 9%) believed that tPA
is a drug undergoing clinical trial and no one felt
that tPA has no role in the treatment of acute
stroke.
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Q4: Regarding Intra-arterial thrombolytic therapy for
acute stroke: 64% felt it was a useful treatment
option; 25% were not aware of this procedure; 2%
believed that it has no role, and 9% thought that it
has only been tried in clinical trials.
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normal saline to be effective, 8% thought 0.45%
saline to be suitable, 6% believed that no intravenous fluid is required for acute ischemic stroke
patients and 18% were not sure about the answer.

Q5: Blood pressure (BP) control in acute stroke: In a
patient with acute stroke with high blood
pressures: of the 100 GPs, 47% felt that the BP
should be lowered - systolic < 185 mmHg and
diastolic < 110 mmHg; 12% felt that the systolic
< 200 mmHg and diastolic < 130 mmHg would
suffice; 25% felt that the BP to be lowered to
normal with systolic 120 mmHg and diastolic 80
mmHg; 2% wanted the BP to be reduced below
normal with systolic <120 mmHg and diastolic
<80 mmHg; and 14% were not sure of what
should be the ideal BP in the setting of acute
stroke

Discussion:
According to WHO statistics, 5.5 million deaths
occurred due to stroke in 2002, estimating 20% of
these deaths occurred in South Asia [6]. The American
Heart & Stroke Association national guidelines recommend tPA to be given within 4.5 hours of symptom
onset in a patient with acute ischemic stroke has
morbidity benefit [7]. However, there is no published
data on the use of thrombolysis in Africa. Although tPA
has demonstrated efficacy in improving outcomes but
its use is often complicated by complex inclusion and
exclusion criteria, risk of haemorrhage, requirement for
intense patient monitoring, substantial cost and the
potential for protocol violations leading to devastating
complications [8].

Q6: Regarding Blood sugar control in stroke: For a
patient with acute ischemic stroke and a blood
glucose of 289 mg/dL: Of the 100 GPs, 9.1% felt
that the high glucose need not be treated; 54.5%
felt that insulin should be started to get the blood
glucose below 200 mg/dl; 13.1% opted for oral
hypoglycemic agents to be effective; and 23.2%
responders were not sure of the management of
blood sugars in stroke.

Q7:

In our setting, quite often the first likely contact of
stroke patients will be a local general practitioner. Therefore, it is cardinal that the local general practitioners
are well aware of the various treatment options
available for the stroke patients and also about the
nearest center providing such treatment options for the
timely and prompt referral. In our survey only 20% of
the GPs opted for tPA as the best treatment option for
a patient with acute ischemic stroke. Only 28% were
aware that tPA needs to be given within the first 3 hours
of symptom onset. Thus in this region of the country
only one out of four potentially treatable cases of acute
ischemic stroke will be referred promptly for possible
thrombolytic therapy. In a German study, two-thirds of
the GPs would immediately admit stroke-suspected
patients [9]. A study in England has shown that visiting
a GP can significantly delay patient arrival at the hospital [10].

Recommended intravenous fluids in acute
ischemic stroke: If intravenous fluids are required
for a patient with acute stroke, of the 100 GPs,
25% opted for dextrose, 43% opted for 0.9%
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There was a very inadequate knowledge seen regarding
blood pressure control and management of blood
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a patient of acute ischemic stroke can immediately call
and clarify instructions regarding timely and prompt
referral for thrombolysis or clear any ambiguities regarding the conservative treatment of acute ischemic
stroke.

25% wanted an aggressive lowering of the BP which
can be potentially detrimental to the patient [11]. High
blood glucose can have disastrous effects on all types
of acute brain injury. In this study, 54% of practicing
general physicians felt the need to aggressively manage
hyperglycemia and still, 25% chose dextrose to be the
intravenous fluid of choice in patients with acute
ischemic stroke. It is also strikingly noticeable that
majority of the GPs chose aggressively marketed neuroprotective drugs like citicoline over tPA.

Conclusion:
Still in the current era of information and technology, a
majority of the GPs are still not aware of the beneficial
effects of thrombolysis and are not updated regarding
blood pressure and glucose control in the setting of
stroke. The patients could reach the emergency department within the window period to be suitable for thrombolytic therapy. There is lack of awareness and knowledge about treatment options in acute ischemic stroke
amongst the referring general practitioners so the
future educational campaigns and programs that will be
organized should focus on the importance of stroke
knowledge among general practitioners.

There are limitations in our study. This survey had
sampled general practitioners only from a small
geographic area of the city and hence the results
cannot be generalized. However, the results of our
study lead to the belief that there is a crucial need to
rationalize and update the knowledge regarding the
treatment of acute ischemic stroke in the midst of GPs
in the country. Following this study, we are planning to
organize a 24-hour acute stroke hotline. Any local
practitioner in this region when coming in contact with
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